- Home
- VNRX vs YI Comparison
VNRX vs YI Comparison
Compare VNRX & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- YI
- Stock Information
- Founded
- VNRX N/A
- YI 2010
- Country
- VNRX United States
- YI China
- Employees
- VNRX N/A
- YI N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- VNRX Health Care
- YI Consumer Staples
- Exchange
- VNRX Nasdaq
- YI Nasdaq
- Market Cap
- VNRX 67.2M
- YI 64.4M
- IPO Year
- VNRX N/A
- YI N/A
- Fundamental
- Price
- VNRX $0.68
- YI $0.63
- Analyst Decision
- VNRX Strong Buy
- YI
- Analyst Count
- VNRX 4
- YI 0
- Target Price
- VNRX $4.17
- YI N/A
- AVG Volume (30 Days)
- VNRX 135.1K
- YI 111.2K
- Earning Date
- VNRX 11-14-2024
- YI 11-27-2024
- Dividend Yield
- VNRX N/A
- YI N/A
- EPS Growth
- VNRX N/A
- YI N/A
- EPS
- VNRX N/A
- YI N/A
- Revenue
- VNRX $1,285,827.00
- YI $2,026,540,888.00
- Revenue This Year
- VNRX $180.66
- YI $61.85
- Revenue Next Year
- VNRX $558.69
- YI N/A
- P/E Ratio
- VNRX N/A
- YI N/A
- Revenue Growth
- VNRX 88.32
- YI 0.38
- 52 Week Low
- VNRX $0.43
- YI $0.55
- 52 Week High
- VNRX $1.23
- YI $2.34
- Technical
- Relative Strength Index (RSI)
- VNRX 50.19
- YI 37.59
- Support Level
- VNRX $0.55
- YI $0.65
- Resistance Level
- VNRX $0.80
- YI $0.70
- Average True Range (ATR)
- VNRX 0.07
- YI 0.05
- MACD
- VNRX 0.01
- YI -0.01
- Stochastic Oscillator
- VNRX 52.00
- YI 11.59
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.